Proceedings of the Texas A&M Medical Student Grand Rounds

A possibility for Prevention: upregulating cellular clearance in Alzheimer’s Disease

July 23, 2018 Mahnoor Zia

Mahnoor Zia

Introduction: Alzheimer’s Disease (AD) is a neurodegenerative disease associated with a progressive memory loss and cognitive disabilities. Neurodegenerative process starts decades before symptoms appear. AD brains have shown two main pathological hallmarks: extracellular accumulation of amyloid-beta (Aβ) plaques and intracellular accumulation of hyperphosphorylated Tau (neurofibrillary tangles, NFT). These pathologies are secondary to mechanical disturbances in cellular clearance, mitochondrial functioning, and oxidative processes. This project focuses on a describing an autophagy mechanism that is downregulated in AD brains and leads to NFTs. Autophagy adapter protein NDP-52 and transcription activator Nrf-2 are the two main intermediates of the pathway. Sulforaphane, an organosulfur compound obtained from cruciferous vegetables, is a Nrf-2 activator. Methods: The cell cultures used in the studies consisted of mice and human cortical cells. X-ray crystallography and NMR on human NDP-52 elucidated its structural and functional domains (1). Nrf-2’s binding sequences on DNA were determined from DNA databases (ENCODE and JASPER)(2). Protein quantification for NDP-52 and Nrf-2 was by western blot and qRT-PCR methods (1,2,3). Phosphorylated Tau was analyzed in tissue samples using immunoblotting and fluorescence antibody assays4. Results: Structural analysis of NDP-52 showed a C-terminal binding domain for ubiquitin and myosin VI, and a separate SIKCH domain for GFP-Tau (1,4). Primary cortical neurons of mice treated with Nrf-2 activator resulted increased NDP-52 mRNA, where as the control showed a reduction in NDP-52 mRNA (4). Nrf-2 was found to be down- regulated in autopsied AD brains (3). Hippocampal tissue obtained from Nrf-2 (-/-) mice showed accumulation of more phosphorylated Tau than tissue samples from Nrf-2 (WT). Methylation specific PCR of mouse neuroblastoma cells treated with sulforaphane showed a decrease in Nrf-2 promoter methylation (3). Furthermore, Western Blot analysis of Nrf2 protein in the nucleus vs. cytoplasm of sulforaphane treated cells had increased level of Nrf2 in the nucleus, while the cytoplasmic protein level remains constant (3). Conclusions: Intracellular Tau tangles have been associated with neurodegeneration and cognitive decline seen in patients with AD. These aggregates are often found in autophagosomes, with halted autophagy. NDP-52 with its binding domain for myosin IV, ubiquitin and phosphorylated Tau is involved in autophagosome maturation. NDP-52 is transcriptionally upregulated by Nrf-2. Therefore, a reduction in Nrf-2, as seen in AD brains, will severely downregulate degradation of phosphorylated Tau by the mechanisms mediated by NDP52. Sulforaphane, can be used to upregulate the process. Consequently, consumption of cruciferous vegetables may be useful in upregulating cellular clearance of NFTs.

 

  1. Xie X, Li F, Wang Y, et al. Molecular basis of ubiquitin recognition by the autophagy receptor CALCOCO2. Autophagy. 2015;11(10):1775-1789.
  2. Pajares M, Moreno N, et al. Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes. Autophagy. 2016; 12 (10); 1902-1916.
  3. Zhao F, Zhang J, Chang N. Epigenetic Modification of Nrf-2 by sulforaphane increases the antioxidative and anti-inflammatory capacity in a cellular model of Alzheimer’sDisease. European Journal of Pharmacology.2018; 824(10); 1-10.
  4. Jo C, Gundemir S. Nrf-2 Reduces Levels of Phosphorylated Tau Protein by inducing Autophagy Adaptor protein NDP 52. Nature Communications. 2014; 5 (3496); 1-13.

 

Neuroscience
Previous Post

Precision Treatment of Rheumatoid Arthritis: Biomarker Signatures and Molecular Methods as Determinates of Drug Response

Next Post

Hypoxia & the Warburg Effect: Exploring Connections Between Lactate Metabolism and Angiogenesis

Scientific Editors

Steve A. Maxwell

Executive Editor
Tel: 979-436-0804
smaxwell@medicine.tamhsc.edu

Robin Fuchs-Young

Deputy Editor
Tel: 979-845-5109
fuchs-young@medicine.tamhsc.edu
Administrative Editor

Janis Chmiel

Tel: 979-436-0856
chmiel@medicine.tamhsc.edu
Editorial Office
Tel.: 979-845-2726
Fax: 979-847-9481
chmiel@medicine.tamhsc.edu
Archives
  • July 2026
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • May 2025
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • November 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • August 2022
  • June 2022
  • May 2022
  • August 2021
  • July 2021
  • April 2021
  • October 2020
  • August 2020
  • July 2020
  • August 2019
  • July 2019
  • February 2019
  • July 2018
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • January 2017
Proudly powered by WordPress | Theme: Fmi by Forrss.